From: Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review
Comp. | (Mean ± SEM) tail withdrawing time in second | Inhibition (%) | ||||
---|---|---|---|---|---|---|
0Â h | 1Â h | 2Â h | 3Â h | 4Â h | 4Â h | |
Control (0.5% CMC) | 0.14 ± 0.01 | 0.23 ± 0.01 | 0.24 ± 0.02 | 0.25 ± 0.01 | 0.25 ± 0.01 | – |
Pentazocine | 0.14 ± 0.01 | 0.12 ± 0.01 | 0.12 ± 0.01 | 0.10 ± 0.01 | 0.09 ± 0.01 | 64 |
21a | 0.14 ± 0.02 | 0.12 ± 0.02 | 0.11 ± 0.01 | 0.11 ± 0.02 | 0.10 ± 0.01 | 60 |
21b | 0.15 ± 0.02 | 0.15 ± 0.01 | 0.13 ± 0.01 | 0.13 ± 0.01 | 0.10 ± 0.01 | 60 |
21c | 0.14 ± 0.01 | 0.13 ± 0.01 | 0.12 ± 0.01 | 0.10 ± 0.11 | 0.09 ± 0.02 | 64 |